Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Announces Publication of Key Preclinical Data for a Novel Oral, First-in-class New Chemical Entity (NCE) Sigma-1 Receptor Antagonist (E-52862), that has Completed Phase I and Initiated its Phase II Clinical Trial Program
7/17/2012 9:56:12 AM
More...
|
Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Opens Second Factory in China
10/28/2010 1:19:07 PM
More...
|
Recordati S.p.A Signs Co-Marketing Agreement With Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) In Spain For Pitavastatin
4/7/2010 10:34:48 AM
More...
|
Esteve S.A. (Laboratorios Del Dr. Esteve S.A.): Innate Immune Mechanisms Can Control Disease Progression In HIV-Positive Patients
2/26/2010 1:33:29 PM
More...
|
Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) And IRSICAIXA Sign Partnership Agreement For The Development Of A Vaccine Against AIDS
1/9/2009 12:11:20 PM
More...
|
Wex Pharmaceuticals Inc. (WXIFF.PK) and Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Terminate Collaboration on Tetrodotoxin
5/14/2007 1:58:57 PM
More...
|
Wex Pharmaceuticals Inc. (WXIFF.PK) Receives EUR 2,000,000 From Co-Development Partner
10/19/2005 5:13:14 PM
More...
|
KV Pharmaceutical Company (KVA) Licenses Two Women's Health Products For Marketing In Spain, Portugal And Andorra
10/19/2005 5:13:10 PM
More...
|
Discovery Laboratories (DSCO) And Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Restructure Their Strategic Alliance
10/19/2005 5:12:24 PM
More...
|
Hemispherx Biopharma (HEB) Initiates Enrollment In HIV/HEP-C Clinical Program; Clinical Trial With Ampligen In Collaboration With Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Targets HIV/HEP-C Twin Epidemics
10/19/2005 5:10:53 PM
More...
|
|